Synthetic cathinone intoxication
Synthetic cathinone intoxication is a clinically significant transient condition that develops during or shortly after the consumption of synthetic cathinones that is characterized by disturbances in consciousness, cognition, perception, affect, behavior, or coordination. These disturbances are caused by the known pharmacological effects of synthetic cathinones and their intensity is closely related to the amount of synthetic cathinones consumed. They are time-limited and abate as the synthetic cathinone is cleared from the body. Presenting features may include anxiety, anger, impaired attention, hypervigilance, psychomotor agitation, paranoid ideation (possibly of delusional intensity), transient auditory hallucinations, transitory confusion, and changes in sociability. Perspiration or chills, nausea or vomiting, and palpitations may be experienced. Physical signs may include tachycardia, elevated blood pressure, pupillary dilatation, dyskinesias and dystonias, and skin sores. In rare instances, usually in severe intoxication, use of synthetic cathinones can result in seizures.
ICD-11 diagnostic criteria
- niedawne użycie syntetycznych katynonów
- objawy odurzenia wynikające z działania farmakologicznego substancji
How to recognise
In the ICD-11 framework, the core symptoms taken into account when recognising Synthetic cathinone intoxication are:
- pobudzenie psychoruchowe
Differential diagnosis
When diagnosing Synthetic cathinone intoxication, the following ICD-11 disorders should be considered in the differential diagnosis:
Frequently asked questions
How is Synthetic cathinone intoxication diagnosed according to ICD-11?
According to ICD-11, the diagnostic criteria for Synthetic cathinone intoxication (6C47.3) include: niedawne użycie syntetycznych katynonów; objawy odurzenia wynikające z działania farmakologicznego substancji.
What disorders are in the differential diagnosis of Synthetic cathinone intoxication?
The differential diagnosis of Synthetic cathinone intoxication (6C47.3) includes: Odurzenie środkami pobudzającymi, w tym amfetaminami, metamfetaminą lub metylkatynonem (6C46.3).
WHO ICD-11 source
View this entry in the official WHO ICD-11 browser: 6C47.3 – WHO ICD-11
Notes
Proszę zakodować również jednostkę chorobową (schorzenie) będące przyczyną
Open in interactive browser →